7月12日晚间，扬子江药业集团微信公众号发布“讣告”，确认扬子江药业集团党委书记、董事长、总经理徐镜人逝世的消息。讣告显示，徐镜人在工作期间突发疾病，经抢救无效，于2021年7月12日晚间逝世，享年77岁。

On the evening of July 12th, the official account of WeChat public of Yangzi Pharmaceutical Group issued an obituary, confirming the news of the death of the party secretary, chairman and general manager of the Yangtze River Pharmaceutical Group. According to the obituary, Xu Jing died on the night of July 12, 2021 at the age of 77.

身家470亿，被称为“板蓝根大王”

With a fortune of 47 billion yuan, he is known as the "king of Banlangen"

资料显示，徐镜人，1944年出生，1971年一手创立扬子江药业集团。扬子江药业集团是科技部命名的全国首批创新型企业。

Data show that Xu Jingren, born in 1944, founded Yangzijiang Pharmaceutical Group in 1971. Yangzijiang Pharmaceutical Group is one of the first batch of innovative enterprises in China named by the Ministry of science and technology.

徐镜人将地处泰州一隅的扬子江药业发展成为现有员工16000余人，旗下20多家成员公司，分布泰州、北京、上海、南京、广州、成都、苏州、常州等地；营销网络覆盖全国各省、市、自治区。

Xu Jingren has developed Yangzijiang pharmaceutical, which is located in the corner of Taizhou, into a company with more than 16000 employees and more than 20 member companies, which are distributed in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou, etc; The marketing network covers all provinces, cities and autonomous regions in China.

对于市场而言，一向神秘低调的徐镜人可能并不为很多人所知，但徐镜人和他的扬子江在中国医药界却是举足轻重，“一代枭雄”“板蓝根大王”，是不少业内人士对徐镜人的评价。

For the market, Xu Jingren, who has always been mysterious and low-key, may not be known to many people. However, Xu Jingren and his Yangzi River play an important role in China's pharmaceutical industry. Many people in the industry comment on Xu Jingren as "a generation of heroes" and "king of Banlangen".

中国医药工业信息中心发布的“2019年度中国医药工业百强榜”显示，扬子江位列当年中国医药工业百强榜首，并且在2014年-2019年期间，连续6年排名第一。2020年发布的国内药企营收榜单数据显示，扬子江营收已经超过千亿。

According to the "top 100 list of China's pharmaceutical industry in 2019" released by China Pharmaceutical Industry Information Center, Yangtze River ranked first in the top 100 list of China's pharmaceutical industry in that year, and ranked first for six consecutive years from 2014 to 2019. According to the revenue list of domestic pharmaceutical enterprises released in 2020, the revenue of Yangtze River has exceeded 100 billion yuan.

2019年福布斯全球亿万富豪榜中，徐镜人排名第394位，财富值47亿美元。2020年他以470亿元人民币财富名列《2020年胡润百富榜》第91位。

Xu Jingren ranked 394 on the Forbes Global list of billionaires in 2019, with a wealth of US $4.7 billion. In 2020, he ranked 91st in Hurun's 2020 100 rich list with a wealth of 47 billion yuan.